Showing results (1181-1190 of 9,207) with videos related to

Sort By:
Pageof 921
Journal of Biomolecular Structure & Dynamics|December 21, 2005
Evidence for long poly(dA).poly(dT) tracts in D. discoideum DNA at high frequencies and their preferential avoidance of nucleosomal DNA core regionsKenneth A Marx, Yue Zhou, Iman Q Kishawi
Nucleosides, Nucleotides & Nucleic Acids|October 27, 2005
Synthesis of oligonucleotides bearing an arylamine modification in the C8-position of 2'-deoxyguanosineC Meier, S Gräsl, I Detmer, et al.
Thrombosis and Haemostasis|October 31, 1984
The inhibitory effect of heparin and related glycosaminoglycans on neutrophil chemotaxisY Matzner, G Marx, R Drexler, et al.
Molecular Microbiology|November 6, 2009
The antifungal protein PAF interferes with PKC/MPK and cAMP/PKA signalling of Aspergillus nidulansUlrike Binder, Christoph Oberparleiter, Vera Meyer, et al.
Plos One|September 30, 2014
Dissociable patterns in the control of emotional interference in adults with attention-deficit/hyperactivity disorder (ADHD) and in adults with alcohol dependenceIvo Marx, John Krause, Christoph Berger, et al.
Pharmacotherapy|October 1, 2014
Early experience with tedizolid: clinical efficacy, pharmacodynamics, and resistanceJeffrey M Rybak, Kayleigh Marx, Craig A Martin
The Journal of Chemical Physics|September 15, 2014
Adding flexibility to the "particles-on-a-sphere" model for large-amplitude motion: POSflex force field for protonated methaneFelix Uhl, Łukasz Walewski, Harald Forbert, et al.
Physical Chemistry Chemical Physics : PCCP|January 13, 2015
Solvation shell resolved THz spectra of simple aqua ions - distinct distance- and frequency-dependent contributions of solvation shellsMaciej Śmiechowski, Jian Sun, Harald Forbert, et al.
Scientometrics|August 8, 2017
Slow reception and under-citedness in climate change research: A case study of Charles David Keeling, discoverer of the risk of global warmingWerner Marx, Robin Haunschild, Bernie French, et al.
Vascular Health and Risk Management|June 29, 2016
SGLT2 inhibitors or GLP-1 receptor agonists as second-line therapy in type 2 diabetes: patient selection and perspectivesHolly E Gurgle, Karen White, Carrie McAdam-Marx
Pageof 921